Global Access Atlas

Evidence & policy library

Every pathway is linked to the organizations responsible for the decision.

Market

15 source records

Methodology

Pathway information draws on official regulator, HTA and payer materials. Consult the cited policy for its conditions and effective date, and see Content & use for guidance on applying Atlas to your research.

Matching documents: 25

Market / scopeOfficial evidence recordTypePolicy / reference dateLast checked

Europe

🇧🇪 BelgiumBE-S01 · FAMHP · Medicinal-product database; Compassionate Use/Medical Need; essential/unavailable medicinesOfficialMA/temporary use, CUP/MNP, supplycurrent frameworkLatest observed: program/list current Jul 20262026-08-01 🇧🇪 BelgiumBE-S01 · FAMHP · Medicinal-product database; Compassionate Use/Medical Need; essential/unavailable medicinesOfficialMA/temporary use, CUP/MNP, supplycurrent frameworkLatest observed: program/list current Jul 20262026-08-01 🇧🇪 BelgiumBE-S01 · FAMHP · Medicinal-product database; Compassionate Use/Medical Need; essential/unavailable medicinesOfficialMA/temporary use, CUP/MNP, supplycurrent frameworkLatest observed: program/list current Jul 20262026-08-01 🇧🇪 BelgiumBE-S02 · FPS Economy / INAMI · Maximum price for reimbursable original medicines; price-request coordinationOfficialsame-day filing, 90/180 days, maximum pricecurrentLatest observed: checked 20262026-08-01 🇧🇪 BelgiumBE-S02 · FPS Economy / INAMI · Maximum price for reimbursable original medicines; price-request coordinationOfficialsame-day filing, 90/180 days, maximum pricecurrentLatest observed: checked 20262026-08-01 🇧🇪 BelgiumBE-S03 · INAMI/RIZIV · Reimbursable-specialties application and CRM/CTGOfficialdossier, evaluation, Minister, publication, reviewAR 2018/currentLatest observed: current 20262026-08-01 🇧🇪 BelgiumBE-S03 · INAMI/RIZIV · Reimbursable-specialties application and CRM/CTGOfficialdossier, evaluation, Minister, publication, reviewAR 2018/currentLatest observed: current 20262026-08-01 🇧🇪 BelgiumBE-S04 · INAMI/RIZIV · Orphan drug reimbursement procedureOfficial180-day clock, conditions, adviser/collegecurrentLatest observed: checked 20262026-08-01 🇧🇪 BelgiumBE-S05 · INAMI/RIZIV · Patient representatives join CRM/CTGOfficialpatient input/governanceeffective 2025-04-01Latest observed: 20252026-08-01 🇧🇪 BelgiumBE-S06 · INAMI/RIZIV · Public parts of Article 81/111 agreements and MORSEOfficialtemporary reimbursement, evidence, compensation, confidentiality/exitcurrentLatest observed: MORSE 20262026-08-01 🇧🇪 BelgiumBE-S06 · INAMI/RIZIV · Public parts of Article 81/111 agreements and MORSEOfficialtemporary reimbursement, evidence, compensation, confidentiality/exitcurrentLatest observed: MORSE 20262026-08-01 🇧🇪 BelgiumBE-S07 · INAMI/RIZIV · Early and Fast Access / EEFAOfficialEarly/Fast eligibility, framework, patient interventioneffective 2026-03-01Latest observed: current Jul 20262026-08-01 🇧🇪 BelgiumBE-S07 · INAMI/RIZIV · Early and Fast Access / EEFAOfficialEarly/Fast eligibility, framework, patient interventioneffective 2026-03-01Latest observed: current Jul 20262026-08-01 🇧🇪 BelgiumBE-S08 · INAMI/RIZIV · Reimbursement-list chapters I–VIIIOfficialchapter purpose, prior/post control, biomarker linkagecurrentLatest observed: checked 20262026-08-01 🇧🇪 BelgiumBE-S09 · INAMI/RIZIV · Reimbursement categories and 2026 copayOfficialA–Fb, patient/hospital sharescurrent 2026Latest observed: 20262026-08-01 🇧🇪 BelgiumBE-S09 · INAMI/RIZIV · Reimbursement categories and 2026 copayOfficialA–Fb, patient/hospital sharescurrent 2026Latest observed: 20262026-08-01 🇧🇪 BelgiumBE-S10 · INAMI/RIZIV · Hospital pharmaceutical forfaitOfficialAPR-DRG forfait and high-cost exclusionssince 2006; update 2024Latest observed: monthly current 20262026-08-01 🇧🇪 BelgiumBE-S11 · FPS Health · Budget des Moyens FinanciersOfficialBMF excludes pharmaceuticalscurrent hospital frameworkLatest observed: BMF 20262026-08-01 🇧🇪 BelgiumBE-S12 · INAMI/RIZIV · Hospital medicine invoicing changes from 2026Official78% billing, hospital absorption, reference/biosimilar lifecycleeffective 2026-01-01Latest observed: 20262026-08-01 🇧🇪 BelgiumBE-S13 · INAMI/RIZIV · Reimbursement-procedure reform roadmapOfficialeffective vs future reform milestonesroadmap 2023–27Latest observed: current 20262026-08-01 🇧🇪 BelgiumBE-S14 · INAMI/RIZIV · Monthly reimbursable-specialties lists and searchOfficialoperational chapter/category/temp statusmonthlyLatest observed: Jul 20262026-08-01 🇧🇪 BelgiumBE-S14 · INAMI/RIZIV · Monthly reimbursable-specialties lists and searchOfficialoperational chapter/category/temp statusmonthlyLatest observed: Jul 20262026-08-01 🇧🇪 BelgiumBE-S15 · European Commission / EMA · EU JCA early-information guidance and EMA IRIS coordinationOfficialscope declaration, parallel notification, product-specific upload and submission-date changes2026-08-19Latest observed: 2026-09-022026-09-06 🇧🇪 BelgiumBE-S15 · European Commission / EMA · EU JCA early-information guidance and EMA IRIS coordinationOfficialscope declaration, parallel notification, product-specific upload and submission-date changes2026-08-19Latest observed: 2026-09-022026-09-06 🇧🇪 BelgiumBE-S15 · European Commission / EMA · EU JCA early-information guidance and EMA IRIS coordinationOfficialscope declaration, parallel notification, product-specific upload and submission-date changes2026-08-19Latest observed: 2026-09-022026-09-06

For education only — not regulatory, pricing or legal advice.